Clinicopathologic factors and serum CA125 level are independent factors affecting the prognosis of ovarian cancer patients, which have been widely used to guide accurate and reasonable clinical treatment, so as to improve the survival rate of patients. Here, MUC16 is linked to ovarian carcinoma.